THERAPEUTIC APHERESIS AND DIALYSIS

Scope & Guideline

Advancing the frontiers of hematology and nephrology.

Introduction

Welcome to your portal for understanding THERAPEUTIC APHERESIS AND DIALYSIS, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1744-9979
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2003 to 2024
AbbreviationTHER APHER DIAL / Ther. Apher. Dial.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal "Therapeutic Apheresis and Dialysis" focuses on advancing the knowledge and practice of therapeutic apheresis and dialysis, encompassing a wide range of conditions and treatment modalities. Its scope includes clinical applications, innovative therapies, and research findings that contribute to the understanding of renal replacement therapies and their impact on patient outcomes.
  1. Therapeutic Apheresis:
    The journal emphasizes the role of therapeutic apheresis in treating various medical conditions, including autoimmune disorders, hematological diseases, and complications arising from chronic kidney disease. It includes studies on the efficacy and safety of procedures such as plasma exchange and leukapheresis.
  2. Dialysis Modalities:
    Research on different dialysis modalities, including hemodialysis and peritoneal dialysis, is a core focus. The journal covers topics related to the optimization of dialysis techniques, patient management, and long-term outcomes of dialysis therapies.
  3. Innovative Treatment Approaches:
    The journal highlights innovative treatment approaches, such as the use of machine learning in predicting patient outcomes, novel dialysis membranes, and blood purification technologies. This includes advancements in therapeutic devices and their clinical applications.
  4. Patient-Centered Care:
    Studies focusing on patient-centered care, quality of life, and psychosocial aspects of treatment in patients undergoing dialysis and apheresis are integral. This includes research on patient education, adherence to treatment, and shared decision-making.
  5. Epidemiology and Outcomes:
    The journal publishes epidemiological studies that assess patient populations undergoing dialysis and apheresis, detailing outcomes related to mortality, morbidity, and complications associated with these therapies.
The journal has shown a dynamic evolution in its research focus, with certain themes emerging as significant areas of interest. These trends reflect current healthcare challenges, technological advancements, and the increasing importance of personalized medicine.
  1. Machine Learning and Predictive Analytics:
    There is a growing trend towards utilizing machine learning and predictive analytics in the management of dialysis and apheresis patients. This includes developing models to predict outcomes such as mortality and treatment response, indicating a shift towards data-driven decision-making.
  2. Patient Quality of Life and Psychosocial Factors:
    Recent publications have increasingly focused on the quality of life, mental health, and psychosocial factors affecting patients undergoing dialysis and apheresis. This trend highlights the importance of holistic care in managing chronic kidney disease.
  3. Advanced Dialysis Technologies:
    Emerging technologies, such as medium-cut-off dialyzers and innovative blood purification methods, are gaining traction in the literature. Research into these advanced modalities aims to improve patient outcomes and reduce complications.
  4. COVID-19 Impact Studies:
    The ongoing impact of COVID-19 on patients undergoing dialysis and apheresis has led to a surge in related research. Studies addressing infection rates, vaccine responses, and management strategies during the pandemic have become increasingly relevant.
  5. Nutritional Interventions:
    An increasing number of studies are focusing on nutritional interventions and their effects on patients undergoing dialysis. This emerging theme explores the links between nutrition, inflammation, and overall health outcomes in this population.

Declining or Waning

While the journal continues to thrive in many areas, certain themes have seen a decline in focus over recent years. These waning scopes may reflect shifting priorities in research or advancements that have reduced the need for investigation in those areas.
  1. Basic Science Research:
    There has been a noticeable decline in basic science research related to the mechanisms of apheresis and dialysis. As clinical applications and outcomes take precedence, foundational studies seem to be less frequently published.
  2. Traditional Dialysis Techniques:
    Research focusing solely on traditional dialysis techniques without innovation or comparative analysis appears to be waning. As newer technologies and methodologies are developed, studies on conventional approaches are becoming less prominent.
  3. Apheresis in Non-Renal Diseases:
    The exploration of apheresis applications in non-renal diseases has decreased. While apheresis remains relevant for renal conditions, its use in broader medical contexts appears less frequently discussed in recent publications.
  4. Longitudinal Studies:
    Longitudinal studies that track outcomes over extended periods have become less common. This may reflect a shift towards more immediate, short-term studies that provide quicker results and insights.
  5. Economic Evaluations:
    Research focusing on the economic aspects of apheresis and dialysis, including cost-effectiveness analyses, seems to be less represented. As funding and resources shift, this area may be receiving less attention.

Similar Journals

CLINICAL NEPHROLOGY

Exploring innovative treatments in nephrology.
Publisher: DUSTRI-VERLAG DR KARL FEISTLEISSN: 0301-0430Frequency: 12 issues/year

CLINICAL NEPHROLOGY is a prestigious academic journal dedicated to advancing the field of nephrology and related areas of medicine. Published by DUSTRI-VERLAG DR KARL FEISTLE, this journal has been a critical resource for researchers and practitioners since its inception in 1973, with a commitment to disseminating high-quality, peer-reviewed articles that provide insights into clinical practices, innovative treatments, and emerging research in kidney diseases. With an ISSN of 0301-0430, CLINICAL NEPHROLOGY stands out in the medical community, achieving a commendable Q3 ranking in both general medicine and nephrology fields as of 2023. The journal's focus on both clinical application and rigorous scientific inquiry makes it an essential read for healthcare professionals and researchers looking to stay at the forefront of nephrology advancements. Although it operates under a subscription model, its broad scope promises invaluable contributions that address practical challenges and foster interdisciplinary dialogue within the healthcare landscape.

Revista de Nefrologia Dialisis y Trasplante

Fostering knowledge and collaboration in kidney health.
Publisher: ASOC REGIONAL DIALISIS TRASPLANTES RENALESISSN: 0326-3428Frequency: 4 issues/year

Revista de Nefrologia Dialisis y Trasplante (ISSN: 0326-3428; E-ISSN: 2346-8548) is a prominent open-access journal published by the ASOC REGIONAL DIALISIS TRASPLANTES RENALES since 2013, located in Buenos Aires, Argentina. This journal serves as a vital platform for the dissemination of pivotal research findings in the fields of nephrology and transplantation, covering a wide range of topics including clinical practices, patient outcomes, and innovative therapies. Although currently ranked in the Q4 category in both Nephrology and Transplantation by Scopus, the journal aims to elevate the discourse within these scientific communities by providing accessible and high-quality research to professionals and researchers alike. With its commitment to advancing knowledge and fostering collaboration among scientists, practitioners, and students, the Revista de Nefrologia Dialisis y Trasplante plays an essential role in addressing the critical challenges and developments in kidney health and organ transplantation.

Kidney360

Empowering nephrology with cutting-edge insights.
Publisher: AMER SOC NEPHROLOGYISSN: 2641-7650Frequency: 12 issues/year

Kidney360 (ISSN: 2641-7650) is a prominent open-access journal published by the American Society of Nephrology, dedicated to advancing the field of nephrology and its intersecting medical disciplines. Established with a vision to foster innovative research and promote a deeper understanding of kidney health, this journal is positioned as a vital resource for nephrologists, researchers, and healthcare professionals. With its classification in Q1 in Nephrology and Q2 in Medicine (miscellaneous) for 2023, Kidney360 ranks favorably, highlighting its commitment to publish high-quality, impactful research, recognized in the top percentile of its field. The journal's accessible platform aims to disseminate knowledge effectively, making it an essential repository for cutting-edge studies, reviews, and clinical research. By encouraging collaboration across various disciplines, Kidney360 plays a critical role in shaping the future of nephrology and enhancing patient care on a global scale.

SEMINARS IN DIALYSIS

Shaping the future of dialysis with cutting-edge research.
Publisher: WILEYISSN: 0894-0959Frequency: 6 issues/year

SEMINARS IN DIALYSIS is a reputable peer-reviewed journal published by WILEY, focusing on advancements in the field of nephrology, particularly in the context of dialysis. With its ISSN 0894-0959 and E-ISSN 1525-139X, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to exploring innovative practices and solutions in kidney health. Since its inception in 1988 and continuing to 2024, the journal has established itself in the Q2 category of nephrology, highlighting its significance in academic discourse, as reflected by its Scopus rank of #42 out of 81 in the field. Although not openly accessible, SEMINARS IN DIALYSIS offers crucial insights into clinical practices and research findings that shape the future of dialysis treatment, making it a cornerstone publication for those dedicated to improving patient outcomes in nephrology.

Hemodialysis International

Elevating Hemodialysis Knowledge and Practice
Publisher: WILEYISSN: 1492-7535Frequency: 4 issues/year

Hemodialysis International is a prominent academic journal dedicated to advancing the field of nephrology and hematology, published by WILEY. With its ISSN 1492-7535 and E-ISSN 1542-4758, this journal serves as a crucial platform for researchers and clinicians to disseminate impactful findings related to hemodialysis and renal care. As it approaches its twentieth year of publication from 2004 to 2024, Hemodialysis International has established itself within the Q3 quartile rankings in both Hematology and Nephrology, reflecting its commitment to scholarly excellence and relevance in the field. Though it is not an open-access journal, it offers various subscription options, making its valuable insights accessible to a broad audience. Researchers, healthcare professionals, and students are encouraged to engage with the journal’s contributions, which encompass innovative research, clinical studies, and reviews, all aimed at improving patient care and outcomes in hemodialysis.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS

Unveiling New Horizons in Biomedical Engineering.
Publisher: SAGE PUBLICATIONS LTDISSN: 0391-3988Frequency: 12 issues/year

International Journal of Artificial Organs is a prestigious peer-reviewed journal published by SAGE Publications Ltd, dedicated to advancing the field of bioengineering, biomaterials, and biomedical engineering. Established in 1978, the journal has a rich history of contributing to the research community with cutting-edge studies and advancements in artificial organ technology and related disciplines. With an impact factor that positions it in the Q3 category across multiple fields, including Medicine and Engineering, the journal serves as a vital resource for researchers, professionals, and students interested in innovative solutions for organ replacement and support. While it is not an open-access journal, it offers subscription-based access, ensuring the dissemination of high-quality research to stakeholders globally. Located in Italy, the journal’s scope encompasses a variety of disciplines, making it essential reading for those at the forefront of medical technology development. Explore the latest breakthroughs and join a community committed to transforming lives through science and engineering.

BLOOD PURIFICATION

Exploring Breakthroughs in Hematology and Nephrology.
Publisher: KARGERISSN: 0253-5068Frequency: 12 issues/year

BLOOD PURIFICATION is a distinguished peer-reviewed journal published by KARGER, recognized for its in-depth exploration of the interdisciplinary topics surrounding blood purification technologies and techniques, encompassing nephrology and hematology. Since its inception in 1983, this reputable journal has provided a vital platform for disseminating groundbreaking research, reviews, and clinical practices aimed at advancing the understanding and management of blood-related conditions. With an impressive impact factor positioned within the second quartile (Q2) in the fields of Hematology, Nephrology, and Miscellaneous Medicine (2023), BLOOD PURIFICATION is highly regarded among researchers and professionals dedicated to enhancing patient outcomes. The journal aims to foster a collaborative academic environment, sharing innovative findings and methodologies, making it an essential resource for scholars, clinicians, and students alike. This publication does not currently offer Open Access options, and is based in Switzerland, with its editorial office located at Allschwilerstrasse 10, CH-4009 Basel. Engage with BLOOD PURIFICATION to stay at the forefront of advancements in blood purification science.

Renal Replacement Therapy

Exploring breakthroughs in nephrology and transplantation.
Publisher: BMCISSN: Frequency: 1 issue/year

Renal Replacement Therapy is an esteemed open-access journal published by BMC, dedicated to advancing the field of nephrology, transplantation, and urology. Established in 2015, the journal aims to disseminate high-quality research findings to enhance the understanding and management of kidney-related diseases and therapies. Renal Replacement Therapy is ranked in the third quartile (Q3) in the categories of Nephrology, Transplantation, and Urology as of 2023, reflecting its growing influence and commitment to academic excellence. The journal encourages interdisciplinary study and collaboration, welcoming contributions from researchers, clinicians, and healthcare professionals. With a focus on practical applications and innovative therapies, this journal is instrumental for those seeking the latest insights and advancements in renal replacement strategies. Located in the United Kingdom, the journal strives to provide unparalleled access to critical research, ensuring that its findings are available to a global audience striving to improve patient outcomes in renal health.

NEPHROLOGY DIALYSIS TRANSPLANTATION

Shaping the future of nephrology with groundbreaking studies.
Publisher: OXFORD UNIV PRESSISSN: 0931-0509Frequency: 12 issues/year

NEPHROLOGY DIALYSIS TRANSPLANTATION is a premier academic journal published by Oxford University Press that plays a vital role in disseminating cutting-edge research within the fields of nephrology and transplantation. With an impressive impact factor and recognition as Q1 in both these categories for 2023, the journal ranks among the top publications in medicine, enhancing its visibility among a global audience of researchers, healthcare professionals, and students. Established in 1986, the journal has maintained a commitment to publishing high-quality, peer-reviewed articles that contribute to the advancement of knowledge and practice in renal medicine. Although this journal does not offer open access options, it remains a highly regarded resource due to its rigorous selection process and influential contributions to the field. Scholars are encouraged to explore the journal’s extensive archive, spanning from 1986 to 2024, for invaluable insights and developments in nephrology and transplantation.

TRANSFUSION AND APHERESIS SCIENCE

Illuminating the Path of Apheresis and Transfusion Science
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1473-0502Frequency: 6 issues/year

TRANSFUSION AND APHERESIS SCIENCE, published by Pergamon-Elsevier Science Ltd, serves as a pivotal platform for researchers and practitioners in the fields of hematology, transfusion medicine, and apheresis. With an ISSN of 1473-0502 and an E-ISSN of 1878-1683, this peer-reviewed journal boasts a respectable Q3 ranking in the Hematology category as of 2023, positioning it within the 45th percentile among its counterparts. Operating from the United Kingdom, it provides comprehensive insights into the latest advancements and methodologies in transfusion practices and apheresis technology, crucial for enhancing patient care and therapeutic strategies. The journal's scope, covering key developments from 1996 to 2024, allows for a deep exploration of historical and emerging trends within the discipline. Moreover, its open access options facilitate widespread dissemination of research findings, fostering collaboration and innovation in the scientific community. For those dedicated to advancing knowledge in hematology, TRANSFUSION AND APHERESIS SCIENCE represents an essential resource, bridging theory and practice in this vital area of healthcare.